Sheba_Medical_Center
Ramat Gan, 52621, Israel
NCT Number: NCT01158014
The use of Fibrin glue to place conjunctival graft will be as effective as suturing the graft, but will require much less operative time and will be better tolerated by the patients.
Looking for future studies?
Notify Me18 year–100 year
All sexes
Interventional
Not applicable
Ramat Gan, 52621, Israel
Pterygium surgery requires removal of the pterygia from cornea and conjunctiva and an additional technique to prevent recurrence which may be as high as 50%.
Suturing a conjunctival auto-graft has become one of the most popular and effective methods in preventing recurrence. However suturing requires long operative time (10-20 minutes with removal alone less than 5 minutes) and requires sutures removal after 1-2 weeks which is very inconvenient to the patient.
Using Fibrin Glue (Quixil) has been used in several places in pterygium surgery and we believe it will be as effective as suturing the graft, will use much less OR time (reduce surgery time from 40 minutes to 20-25 minutes) and will be less expensive since 2 ml glue (around 80US$) suffice for 10 cases, while one vicryl suture costs around 34 US$.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
quixil 0.1 ml
vicryl 10/0
Time frame: one year
Recurrence normally occurs 1-6 months after surgery. Success is achieved if ptergium does not recur after one year.
Time frame: one year
suturing a conjunctival graft takes 15-10 minutes while gluing only 5 minutes, we believe that by lowering OR time, total costs of surgery are less
Dr. Guy Ben-Simon, MD
Other Gov
Fibrin Glue vs. Vicryl Suture in Pterygium Surgery With Conjunctival Auto-graft
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05314673
Conjunctival Diseases, Disease Attributes
Aryanah, Illinois, Tunisia
View Trial DetailsNCT02342392
Conjunctival Diseases, Disease Attributes
View Trial DetailsNCT00949728
Conjunctival Diseases, Disease Attributes
Joinville, Santa Catarina, Brazil
View Trial DetailsNCT01134575
Acute Lymphoblastic Leukemia, Burkitt Lymphoma
Houston, Texas, United States
View Trial Details